Literature DB >> 1672149

Characterization of the release of cholecystokinin-8 from isolated nerve terminals and comparison with exocytosis of classical transmitters.

M Verhage1, W E Ghijsen, D G Nicholls, V M Wiegant.   

Abstract

In the present study, the release of the neuropeptide cholecystokinin-8 (CCK) from purified nerve terminals (synaptosomes) of the rat hippocampus was characterized with respect to the subcellular distribution, the release upon addition of various agents, the release kinetics, the Ca2+ and ATP dependence of release, and the relationship between CCK release and elevations of intraterminal free Ca2+ concentration ([Ca]i). These characteristics were compared with those for the release of classical transmitters in similar preparations. CCK-like immunoreactivity (CCK-LI) is enriched in the purified synaptosomal fraction of hippocampus homogenates and released in a strictly Ca2(+)-dependent manner upon chemical depolarization, addition of 4-aminopyridine, or stimulation with the Ca2+ ionophore ionomycin. The presence of Ca2+ in the medium significantly stimulates the basal efflux of CCK-LI from synaptosomes. The release upon stimulation develops gradually in time with no significant release in the first 10 s and levels off after 3 min of depolarization. At this time, a large amount of CCK-LI is still present inside the synaptosomes. A correlation exists between the release of CCK-LI and the elevations of [Ca]i. The release of CCK-LI is decreased, but not blocked, upon ATP depletion. These characteristics markedly differ from those for classical transmitters, which show a fast component of Ca2(+)-dependent (exocytotic) release, an absolute dependence on cellular ATP, and no marked stimulation of basal efflux in the presence of Ca2+.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672149     DOI: 10.1111/j.1471-4159.1991.tb11437.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Syntaxin modulation of calcium channels in cortical synaptosomes as revealed by botulinum toxin C1.

Authors:  J B Bergsman; R W Tsien
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 2.  Bioenergetics and transmitter release in the isolated nerve terminal.

Authors:  David G Nicholls
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

3.  Mechanisms of the release of anterogradely transported neurotrophin-3 from axon terminals.

Authors:  XiaoXia Wang; Rafal Butowt; Michael R Vasko; Christopher S von Bartheld
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 4.  Mechanisms in the regulation of neurotransmitter release from brain nerve terminals: current hypotheses.

Authors:  T S Sihra; R A Nichols
Journal:  Neurochem Res       Date:  1993-01       Impact factor: 3.996

5.  Release of secretoneurin and noradrenaline from hypothalamic slices and its differential inhibition by calcium channel blockers.

Authors:  J Troger; R Kirchmair; J Marksteiner; C V Seidl; R Fischer-Colbrie; A Saria; H Winkler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

Review 6.  Cholecystokinin: a multi-functional molecular switch of neuronal circuits.

Authors:  Soo Yeun Lee; Ivan Soltesz
Journal:  Dev Neurobiol       Date:  2011-01-01       Impact factor: 3.964

7.  The differential release of amino acids and neuropeptides from purified subpopulations of mammalian GABAergic and cholinergic cerebrocortical synaptosomes.

Authors:  P D Hughes; P Foley; H F Bradford; M Ghatei; N Khandanian; S R Bloom; J Y Wu
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

8.  Relation of exocytotic release of gamma-aminobutyric acid to Ca2+ entry through Ca2+ channels or by reversal of the Na+/Ca2+ exchanger in synaptosomes.

Authors:  C B Duarte; I L Ferreira; A P Carvalho; C M Carvalho
Journal:  Pflugers Arch       Date:  1993-05       Impact factor: 3.657

9.  Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.

Authors:  J Shlik; E Vasar; J Bradwejn
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.